About Capstan Therapeutics
Capstan Therapeutics is a private company based in San Diego, California, incorporated in 2020 in Delaware. It has reported $226,999,957 raised in three offerings on Form D since March 2024. Its chief executive is Laura Shawver.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 24, 2021 | Mar 20, 2024 | $62,999,992fully sold | 9 | $6.9M | EquityRule 506(b) | Form D ↗ |
| Jun 14, 2022 | Mar 20, 2024 | $76,499,983of $101.9M target | 14 | $5.4M | EquityRule 506(b) | Form D ↗ |
| Mar 5, 2024 | Mar 20, 2024 | $87,499,982of $174.9M target | 21 | $4.1M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $226,999,957 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Capstan Therapeutics's Form D filed Mar 20, 2024.
FP
Fabio Pucci
Director
NS
Nandita Shangari
Director
MS
Michal Silverberg
Director
Erez Chimovits
Director
Also a director at ADARx Pharmaceuticals and ImmPACT Bio USA, a senior managing director at orbimed at Fore Biotherapeutics and an executive officer at OrbiMed Partners.
AC
Athena Countouriotis
Director
RJ
Rajul Jain
Director
Also a director at Lb Pharmaceuticals, Quanta Therapeutics and SonoThera and an executive officer at Vida Ventures.
LS
Laura Shawver
President and CEO, director
RF
Ramin Farzaneh-Far
Executive officer
JT
Justin Thacker
Executive officer
MB
Michael Baran
Director
AB
Adrian Bot
Executive officer
NL
Nanna Luneborg
Director
PK
Priya Karmali
Executive officer
KS
Karen Smith
Director